ArticleNPJ precision oncology2025
Customized transformer for lymph node metastasis prediction from lung adenocarcinoma histology in a multicentric study.
Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hybrid supervised deep learning for lung adenocarcinoma diagnosis to optimize surgical strategies.NPJ precision oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Reliable lymph node metastasis (LNM) assessment underpins staging and treatment decisions in lung adenocarcinoma (LUAD), yet approximately 10% of patients remain pNx due to sampling limitations. Existing LNM prediction methods mainly rely on imaging or molecular data, while the potential of histopathological whole-slide images (WSIs) remains underexplored. We introduce CTMIL, a customized transformer-based multiple instance learning framework for predicting LNM directly from primary LUAD WSIs. Three CTMIL models were trained on 320 TCGA cases using patch-level features extracted from ResNet50, InceptionResNetV2, and UNI backbones, and internally validated on 80 held-out cases. External evaluation on two independent cohorts (XY cohort, 149 cases, and RM cohort, 164 cases) showed that CTMIL models consistently outperformed attention-based, TransMIL, and baseline approaches under identical inputs. The best-performing model, UNI_CTMIL, achieved AUROCs of 0.8640, 0.8216, and 0.8090 on the validation, XY, and RM cohorts, respectively. Interpretability analyses showed that UNI_CTMIL attends to metastatic hallmarks such as micropapillary and solid patterns, mucin, poor differentiation, and high tumor cell density. These findings highlight CTMIL's promise for histology-based LNM prediction, potentially in pNx cases.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.